3,572 Shares in Grail, Inc. (NASDAQ:GRAL) Acquired by Wilmington Savings Fund Society FSB

Wilmington Savings Fund Society FSB acquired a new stake in shares of Grail, Inc. (NASDAQ:GRALFree Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,572 shares of the company’s stock, valued at approximately $64,000.

Several other institutional investors and hedge funds have also bought and sold shares of GRAL. abrdn plc bought a new stake in Grail in the fourth quarter valued at $3,768,000. China Universal Asset Management Co. Ltd. purchased a new stake in shares of Grail in the 4th quarter worth about $127,000. Perigon Wealth Management LLC bought a new stake in shares of Grail during the 4th quarter valued at about $260,000. Slow Capital Inc. bought a new stake in shares of Grail during the 4th quarter valued at about $2,379,000. Finally, Exchange Traded Concepts LLC purchased a new position in shares of Grail during the fourth quarter valued at about $507,000.

Insider Transactions at Grail

In related news, CFO Aaron Freidin sold 30,452 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the completion of the transaction, the chief financial officer now owns 268,277 shares of the company’s stock, valued at $3,761,243.54. This trade represents a 10.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Grail Stock Up 33.9 %

NASDAQ:GRAL opened at $52.58 on Friday. The firm’s 50-day moving average price is $22.67 and its 200-day moving average price is $17.58. Grail, Inc. has a 1-year low of $12.33 and a 1-year high of $52.85.

Grail (NASDAQ:GRALGet Free Report) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($3.94) earnings per share for the quarter. The business had revenue of $28.65 million for the quarter. As a group, sell-side analysts predict that Grail, Inc. will post -65.16 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have commented on GRAL shares. Wolfe Research began coverage on shares of Grail in a report on Friday, November 15th. They issued a “peer perform” rating for the company. Morgan Stanley assumed coverage on Grail in a research note on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 target price for the company. Finally, Guggenheim began coverage on Grail in a research note on Thursday, October 17th. They issued a “neutral” rating on the stock.

Read Our Latest Research Report on GRAL

Grail Profile

(Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Featured Stories

Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Grail, Inc. (NASDAQ:GRALFree Report).

Institutional Ownership by Quarter for Grail (NASDAQ:GRAL)

Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.